过去一年中添加的文章,按日期排序

[HTML][HTML] Synergistic Integration of Life Cycle Assessment and Life Cycle Costing for a Performance-Oriented Structural Design with Advanced Cement-Based Materials

D di Summa - 2024 - biblio.ugent.be
3 天前 - … , like lack of data regarding the usage and end-of-life phases when novel materials
are … regarding durability when exposed to aggressive environments, have been carried out …

When Life-Supporting Interventions Lead to Moral Distress

K Hudgins - Critical Care Nursing Quarterly, 2024 - journals.lww.com
10 天前 - … in caring for the dying has been increasing, and many of these inadequacies are
related to the use of aggressive treatment and advanced life support in critical care settings. …

Palliative Care in the Intensive Care Unit: The Standard of Care

C Wiencek - AACN Advanced Critical Care, 2024 - AACN
13 天前 - … of blending the intensive care unit goals of aggressive treatment and cure with
the palliative care goals of symptom management and quality of life. Today, palliative care is …

Pharmacokinetic/pharmacodynamic issues for optimizing treatment with beta-lactams of Gram-negative infections in critically ill orthotopic liver transplant recipients: a …

M Gatti, F Pea - Frontiers in Antibiotics - frontiersin.org
17 天前 - Orthotopic liver transplant (OLT) represents the standard of care for managing
patients affected by end-stage and life-threatening liver diseases. Although a significant …

[HTML][HTML] Knowledge and Perceptions of the End of Life among Tunisian Medical and Paramedical Staff

N Khessairi, D Bacha, R Aouadi… - Journal of Hospice …, 2024 - ncbi.nlm.nih.gov
20 天前 - Purpose End-of-life (EOL) care is a vulnerable period in an individual’s life. Healthcare
professionals (HPs) strive to balance the preservation of human life with respect for the …

[引用][C] EE206 Cost-Effectiveness Analysis for Acalabrutinib in the Treatment of Patients With Relapsed/Refractory Mantle Cell Lymphoma (r/r MCL) in China

S Chang, X He - Value in Health, 2024 - valueinhealthjournal.com
20 天前 - Objectives MCL is a rare and aggressive subtype of non-Hodgkin lymphoma (NHL),
accounting for 3.5% of all incident NHL cases in China. Acalabrutinib and ibrutinib are BTK …

Efficacy of sacituzumab govitecan in a patient with TNBC with early relapse after neoadjuvant chemotherapy.

F Carlino, S Feliciano - Recenti Progressi in Medicina, 2024 - europepmc.org
20 天前 - aggressive subtype of breast cancer) in women who have received at least two prior
chemotherapy treatments in … with early relapse after neoadjuvant treatment. In this clinical …

Comparison of concurrent care and traditional hospice at a regional VA.

JS Zhang, RA Hadler, A Broderick, WA Zeitler - 2024 - ascopubs.org
22 天前 - … Initial national VA data in lung cancer suggested that concurrent care may be
better than traditional hospice by decreasing aggressive treatments, ICU hospitalizations, and …

A phase I/IIa of [212Pb]VMT01 targeted a-particle therapy for unresectable or metastatic melanoma.

ZS Morris, M Puhlmann, F Johnson, A Hanna, SY Cho - 2024 - ascopubs.org
23 天前 - TPS9610 Background: Melanoma is an aggressive skin cancer with potential to
metastasize early in disease development. Unresectable and metastatic melanoma accounts …

Behavioral economic interventions to embed early palliative care in community oncology (BE-EPiC): A pragmatic cluster-randomized trial.

R Sedhom, WJ Ferrell, J Chen, K Villarin, Y Li… - 2024 - ascopubs.org
23 天前 - … care (PC) concurrent with cancer-directed treatment improves quality of life and
symptom burden, decreases aggressive end-of-life care, and is endorsed by national guidelines…